Corporate Profile | Nikon CeLL innovation

Company Name	Nikon CeLL innovation Co. Ltd.
Shareholder	Nikon Corporation (100%)
Establishment	May 7th, 2015
Head Office	1-7-11,nishioi,Shinagawa-ku,Tokyo 140-0015,Japan
Facility	Tokyo Grand Port AKB, 2-4-10 Shinsuna, Koto-Ku, Tokyo 136-0075 Japan
CDMO Service Offering	Cell and Gene Therapy Process Development (CDO) Cell and Gene Therapy Manufacturing Service (CMO)
Features	Exclusive Collaboration with Lonza to further development of Cell and Gene Therapy manufacturing in Japan One of the Largest CDMO facility in Japan (7,500 m²) Process Development Technology Transfer Process Development/Optimization Assay Development/Optimization Process Scale-up/Scale-out GCTP / GMP Manufacturing Service Autologous, Allogeneic Cells. Cell Isolation, Expansion and Differentiation Master Cell Bank Production Various Gene Modification Techniques Quality Control Quality Assurance Supply Chain (storage, shipping, and logistics) Regulatory Support